{"id":"https://openalex.org/W2089694151","doi":"https://doi.org/10.4088/jcp.v66n0803","title":"Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors: A Meta-Analysis of Original Data From 7 Randomized Controlled Trials","display_name":"Remission Rates Following Antidepressant Therapy With Bupropion or Selective Serotonin Reuptake Inhibitors: A Meta-Analysis of Original Data From 7 Randomized Controlled Trials","alternate_titles":[],"publication_year":2005,"publication_date":"2005-08-15","ids":{"openalex":"https://openalex.org/W2089694151","doi":"https://doi.org/10.4088/jcp.v66n0803","mag":"2089694151","pmid":"https://pubmed.ncbi.nlm.nih.gov/16086611"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v66n0803","doi":"https://doi.org/10.4088/jcp.v66n0803","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v66n0803","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2089694151"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085107940","display_name":"Michael E. Thase","orcid":"https://orcid.org/0000-0002-6403-0861","observed_orcids":["https://orcid.org/0000-0002-6403-0861","https://orcid.org/0009-0002-3646-845X"]},"institutions":[{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E. Thase","raw_affiliation_strings":["Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA 15213-2593, USA. thaseme@upmc.edu","Department of Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, Pittsburgh, PA, US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA 15213-2593, USA. thaseme@upmc.edu","institution_ids":["https://openalex.org/I4210134769"]},{"raw_affiliation_string":"Department of Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, Pittsburgh, PA, US","institution_ids":["https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109178444","display_name":"Barbara R. Haight","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara R. Haight","raw_affiliation_strings":["Glaxosmithkline, Research Triangle Park, NC/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Research Triangle Park, NC/US","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nathalie Richard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathalie Richard","raw_affiliation_strings":["Glaxosmithkline, Research Triangle Park, NC/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Research Triangle Park, NC/US","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011311162","display_name":"Carol B. Rockett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol B. Rockett","raw_affiliation_strings":["Glaxosmithkline, Research Triangle Park, NC/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Research Triangle Park, NC/US","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031596591","display_name":"Melinda W. Mitton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melinda Mitton","raw_affiliation_strings":["Glaxosmithkline, Research Triangle Park, NC/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Research Triangle Park, NC/US","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025148574","display_name":"Jack G. Modell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack G. Modell","raw_affiliation_strings":["Glaxosmithkline, Research Triangle Park, NC/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Research Triangle Park, NC/US","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034420576","display_name":"Susan A. VanMeter","orcid":"https://orcid.org/0000-0001-5994-803X","observed_orcids":["https://orcid.org/0000-0001-5994-803X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan VanMeter","raw_affiliation_strings":["Glaxosmithkline, Research Triangle Park, NC/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Research Triangle Park, NC/US","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067063368","display_name":"April E. Harriett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"April E. Harriett","raw_affiliation_strings":["Glaxosmithkline, Research Triangle Park, NC/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Research Triangle Park, NC/US","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053444692","display_name":"Younghua Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Younghua Wang","raw_affiliation_strings":["Glaxosmithkline, Research Triangle Park, NC/US"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxosmithkline, Research Triangle Park, NC/US","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":12.1196,"has_fulltext":false,"cited_by_count":339,"citation_normalized_percentile":{"value":0.99138859,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"66","issue":"08","first_page":"974","last_page":"981"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10214","display_name":"Psychotherapy Techniques and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bupropion","display_name":"bupropion","score":0.9810000061988831},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9179999828338623},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8849999904632568},{"id":"https://openalex.org/keywords/remission-rate","display_name":"remission rate","score":0.9079999923706055},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.7149999737739563},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7429999709129333},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.8119999766349792},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.9940000176429749},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/norepinephrine-dopamine-reuptake-inhibitors","display_name":"norepinephrine-dopamine reuptake inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.550000011920929}],"concepts":[{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.9580861330032349},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.8502802848815918},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.6817963123321533},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6699362993240356},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.6434999704360962},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5484335422515869},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5369484424591064},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5332075953483582},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4974839985370636},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.4484262764453888},{"id":"https://openalex.org/C2779583969","wikidata":"https://www.wikidata.org/wiki/Q423757","display_name":"Escitalopram","level":4,"score":0.4272809624671936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4257700741291046},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4032684862613678},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3716197609901428},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.21794161200523376},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.15572583675384521},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v66n0803","doi":"https://doi.org/10.4088/jcp.v66n0803","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v66n0803","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:16086611","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16086611","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[{"id":"https://openalex.org/G96926792","display_name":null,"funder_award_id":"MH30915","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2017898544","https://openalex.org/W2340565776","https://openalex.org/W2067998521","https://openalex.org/W2017331101","https://openalex.org/W2121675770","https://openalex.org/W2049177233","https://openalex.org/W1991296006","https://openalex.org/W2140787893","https://openalex.org/W2434159421","https://openalex.org/W3167272489"],"abstract_inverted_index":{"BACKGROUND:":[0],"Although":[1,201],"it":[2],"is":[3],"widely":[4],"believed":[5],"that":[6,266],"the":[7,47,126,130,139,161,197,247],"various":[8],"classes":[9],"of":[10,25,28,37,44,73,146,192,216],"antidepressants":[11],"are":[12],"equally":[13],"effective,":[14],"clinically":[15],"meaningful":[16],"differences":[17],"may":[18],"be":[19],"obscured":[20],"in":[21,97,124,212],"individual":[22],"studies":[23,45,77,107],"because":[24],"a":[26,35,41,70],"lack":[27],"statistical":[29],"power.":[30],"The":[31,154,189,259],"present":[32],"report":[33],"describes":[34],"meta-analysis":[36],"original":[38],"data":[39,66],"from":[40,69],"complete":[42,71],"set":[43,72],"comparing":[46,78],"norepinephrine/dopamine":[48],"reuptake":[49,56],"inhibitor":[50],"(NDRI)":[51],"bupropion":[52,79,162,202,224,237,276],"with":[53,83,99,231,240,275],"selective":[54],"serotonin":[55],"inhibitors":[57],"(SSRIs;":[58],"sertraline,":[59,89],"fluoxetine,":[60],"or":[61,104,122],"paroxetine).":[62],"METHOD:":[63],"Individual":[64],"patient":[65],"were":[67,117,150,172,177,205,228,249,256],"pooled":[68],"7":[74],"randomized,":[75],"double-blind":[76],"(N":[80,110],"=":[81,87,91,95,111],"732)":[82],"SSRIs":[84,204,227,248],"(fluoxetine,":[85],"N":[86,90,94],"339;":[88],"343;":[92],"paroxetine,":[93],"49)":[96],"outpatients":[98],"major":[100],"depressive":[101],"disorder":[102],"(DSM-III-R":[103],"DSM-IV);":[105],"4":[106],"included":[108],"placebo":[109,180],"512).":[112],"Response":[113],"and":[114,138,157,164,166,169,182,203,225,234,236,246],"remission":[115,158],"rates":[116,159,215],"compared":[118,221],"at":[119],"week":[120],"8":[121],"endpoint":[123],"both":[125,174,223,254],"intent-to-treat":[127],"sample,":[128],"using":[129],"last-observation-carried-forward":[131],"(LOCF)":[132],"method":[133],"to":[134,179,222],"account":[135],"for":[136,160],"attrition,":[137],"observed":[140,198],"cases.":[141],"Tolerability":[142],"data,":[143],"including":[144],"incidence":[145],"sexual":[147,217,267,280],"side":[148,218],"effects,":[149],"also":[151,229],"compared.":[152],"RESULTS:":[153],"LOCF":[155],"response":[156],"(62%":[163],"47%)":[165,170],"SSRI":[167,209,271],"(63%":[168],"groups":[171],"similar;":[173],"active":[175],"therapies":[176],"superior":[178],"(51%":[181],"36%;":[183],"all":[184],"comparisons,":[185],"p":[186],"<":[187],".001).":[188],"same":[190],"pattern":[191],"results":[193],"was":[194,238,265],"demonstrated":[195],"on":[196],"cases":[199],"analyses.":[200],"generally":[206],"well":[207,257],"tolerated,":[208],"therapy":[210],"resulted":[211],"significantly":[213],"higher":[214],"effects":[219],"as":[220],"placebo.":[226,283],"associated":[230,239],"more":[232,241,279],"somnolence":[233],"diarrhea,":[235],"dry":[242],"mouth.":[243],"CONCLUSION:":[244],"Bupropion":[245],"equivalently":[250],"effective":[251],"and,":[252],"overall,":[253],"treatments":[255,264],"tolerated.":[258],"principal":[260],"difference":[261],"between":[262],"these":[263],"dysfunction":[268,281],"commonly":[269],"complicated":[270],"therapy,":[272],"whereas":[273],"treatment":[274],"caused":[277],"no":[278],"than":[282]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2089694151","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":23},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":21},{"year":2012,"cited_by_count":25}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
